10 Best Ways to Prevent Type 2 Diabetes

In This Article:

In this article, we shall discuss the 10 best ways to prevent type 2 diabetes. To skip our detailed analysis of the global diabetes industry and the larger pharmaceutical industry in 2023, go directly and see 5 Best Ways to Prevent Type 2 Diabetes

Diabetes is directly responsible for more than 280,000 deaths each year. As fast food consumption and obesity levels reach an all time high, the global diabetes market is projected to adapt accordingly. With a significant increase in the global diabetic population, technological advancements, and rising adoption rates in emerging regions, the global diabetes industry is projected to reach more than $118 billion by 2031, growing at a CAGR of 6.67% during the forecast period. According to an article by Bloomberg, over 1.3 billion people globally are projected to have diabetes by 2050, causing patients to look for the best ways to prevent type 2 diabetes. Some of the biggest players in the insulin industry are Merck & Co. (NYSE:MRK), Eli Lilly and Company (NYSE:LLY), and Abbott Laboratories (NYSE:ABT).

Don't Miss: 20 Most Addictive Foods According to Science.

The Rise of Digital Therapeutics: An Analysis

As the burden of chronic diseases like diabetes exacerbate the economic crisis globally, the challenges have created a requirement for comprehensive disease management solutions. Since chronic conditions like diabetes are largely untreatable and need to be managed through lifelong medication and care, disease burdens at a population level are higher than they need to be. The need to integrate digital technologies with biotech seems to be more pronounced than ever as one of the best ways to prevent type 2 diabetes. According to an article by McKinsey, global digital health funding increased by more than 79% compared to 2022 to reach $57.2 billion in 2023. Much of this funding  has largely been reserved for digital therapeutics, which include numerous points of intervention along the patient's journey, comprising of monitoring, medication, adherence, behavioral engagement, personalized coaching, and real time custom health recommendations. Funding for digital therapeutics has grown at a massive scale - nearly 134 percent up from 2022 to reach nearly $9 billion in 2023.

According to another study by McKinsey, digital therapeutics offer pharmaceutical companies access to new sections of the healthcare value chain and an opportunity to operate in the much larger, more lucrative end-to-end healthcare market. Incumbent pharmaceuticals already have some inherent advantages in that they already boast direct access to patients, intrinsic knowledge of pain points in the disease management journey, and profound experience with providing some of the best ways to prevent type 2 diabetes. However, for a successful infiltration into the digital therapeutics market, pharmaceutical companies may need to recruit or upskill employees with skills in product development, design, data science, and strategic partnerships. They should construct five year plans to build on their digital capabilities and affiliate their new digital workforce with the culture, vision, mission and values to compete against start-ups. Companies which adapt quickly will have first-mover advantage, which is why investors are flocking to stocks like Merck & Co. (NYSE:MRK), Eli Lilly and Company (NYSE:LLY), and Abbott Laboratories (NYSE:ABT), which have diverted significant investment in rewiring their technology, tools, and operating models to realize their digital and analytics ambitions in 2023. To read more on companies which have integrated digital technology in their product portfolio, read our article on 11 Best Digital Technology Stocks to Buy.